Royal Dutch Shell Plc said it signed an agreement to sell its 75 percent stake in Tongyi Lubricants in China to Huo’s Group and private-equity firm Carlyle Group LP., Reuters reported.Continue
First Read ushers in your morning with news of Royal Dutch Shell planning on acquiring [...]Continue
Blackstone Group LP is close to a deal to buy a 50 percent stake worth $1.2 billion in a gas field in Louisiana currently owned by Royal Dutch Shell, a source told Reuters.Continue
Global commodity trader Noble Group Ltd has joined forces with a private equity group to set up an energy investment fund run by a former Royal Dutch Shell executive, its second such arrangement in a year, Reuters reported.Continue
Oil majors have put up for sale assets worth more than $300 billion and more [...]Continue
Chrysalix said it signed three new strategic limited partners to its CELP III Fund. They are SABIC, Royal Dutch Shell, and a large European industrial group to be disclosed this spring. The new LPs will give CELP III additional money to strengthen the fund’s portfolio, especially important during a recessionary period, the venture firm said. […]Continue
Barra Energia, the Brazilian oil and gas company based in Rio de Janeiro, has closed a deal to buy the remaining 10 percent of Royal-Dutch Shell‘s stake in a deep-water subsalt exploration block off Brazil’s coast. Shell said the sale was part of a previously announced reshuffle of its asset portfolio. It plans to continue investing in Brazil and expects […]Continue
BP Stock is now a buy: Shares of BP, now subject to takeover and bankruptcy rumors, are up. And only a few companies, Shell, Exxon Mobil or Chevron, could take it on. So it’s a buy now.
Who wants Wendy’s: Shares of the fast food chain pop Friday on rumors that it could be taken over.
Sophisticated Investors not so smart: Investors of Merrill Lynch-issued CDOs claims they were bright enough to read the fine print.Continue
Royal Dutch Shell has increased its equity stake in Codexis Inc., a developer of industrial biocatalysts, including enzymes and microbes. No financial terms were disclosed for the deal, which was part of a larger strategic arrangement. Codexis last year canceled plans for a $100 million IPO. At the time, it had raised over $80 million from CCTV Investments, CMEA Ventures, Pequot Capital, Pfizer, Maxygen and Bio*One Capital.Continue